Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women with advanced ovarian cancer who are in complete or partial remission after surgery, and for whom a doctor has determined that oral PARP inhibitor treatment is appropriate — either alongside chemotherapy as a first-line treatment or as a maintenance therapy afterward.
Who may not be able to join:
- People who had abnormal blood cell counts before starting PARP inhibitor treatment.
- People whose bone marrow has been affected by ovarian cancer cells spreading into it.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Federica Gigli, Istituto Europeo di Oncologia
Phone: +390257489538
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of the events and determination of their incidence in study patient's population:
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.